Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar;21(3):236-246.
doi: 10.6004/jnccn.2023.0014.

NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023

Kelvin A Moses  1 , Preston C Sprenkle  2 , Clinton Bahler  3 , Geoffrey Box  4 , Sigrid V Carlsson  5 , William J Catalona  6 , Douglas M Dahl  7 , Marc Dall'Era  8 , John W Davis  9 , Bettina F Drake  10 , Jonathan I Epstein  11 , Ruth B Etzioni  12 , Thomas A Farrington  13 , Isla P Garraway  14 , David Jarrard  15 , Eric Kauffman  16 , Deborah Kaye  17 , Adam S Kibel  18 , Chad A LaGrange  19 , Paul Maroni  20 , Lee Ponsky  21 , Brian Reys  22 , Simpa S Salami  23 , Alejandro Sanchez  24 , Tyler M Seibert  25 , Terrence M Shaneyfelt  26 , Marc C Smaldone  27 , Geoffrey Sonn  28 , Mark D Tyson  29 , Neha Vapiwala  30 , Robert Wake  31 , Samuel Washington  32 , Alice Yu  33 , Bertram Yuh  34 , Ryan A Berardi  35 , Deborah A Freedman-Cass  35
Affiliations

NCCN Guidelines® Insights: Prostate Cancer Early Detection, Version 1.2023

Kelvin A Moses et al. J Natl Compr Canc Netw. 2023 Mar.

Abstract

The NCCN Guidelines for Prostate Cancer Early Detection provide recommendations for individuals with a prostate who opt to participate in an early detection program after receiving the appropriate counseling on the pros and cons. These NCCN Guidelines Insights provide a summary of recent updates to the NCCN Guidelines with regard to the testing protocol, use of multiparametric MRI, and management of negative biopsy results to optimize the detection of clinically significant prostate cancer and minimize the detection of indolent disease.

PubMed Disclaimer